(HIBL) Direxion Daily SP500 High - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US25460G8565 • Trading--Leveraged Equity

HIBL: Stocks, Options, Futures, Derivatives

The Direxion Daily S&P 500® High Beta Bull 3X Shares (HIBL) is a leveraged exchange-traded fund (ETF) designed to provide 3X daily returns of the S&P 500® High Beta Index. The fund typically allocates at least 80% of its net assets to financial instruments that replicate the indexs performance, amplified threefold. This includes derivatives such as futures contracts and swaps. The index itself is composed of 100 securities selected from the S&P 500® Index, chosen for their high sensitivity to market movements, measured by beta over the past year. The fund is classified as non-diversified, meaning it can concentrate its holdings in a smaller number of securities, which may increase volatility.

HIBL is part of the leveraged equity category, targeting traders and investors seeking amplified exposure to high-beta stocks within the S&P 500®. The fund resets its leverage daily, meaning returns are calculated and rebalanced every trading day. This daily reset can lead to compounding effects, where returns over multiple days may not perfectly align with the target multiple of the underlying indexs performance. Additionally, the funds high leverage makes it more suitable for short-term trading strategies rather than long-term investment.

Ticker Symbol: HIBL Exchange: NYSE ARCA Type: ETF Country Origin: USA ETF Category: Trading--Leveraged Equity Average Volume 20d: 106,051 Last Price: 31.75 SMA 20: 41.30 SMA 50: 43.61 SMA 200: 43.18 ATR: 2.84 AUM: $32.46M USD

Based on the provided data, HIBLs 3-month forecast suggests heightened volatility, with price movements likely confined between $28 and $35. The funds SMA 20 and SMA 50 indicate a downward trend, with the 20-day moving average falling below the 50-day average. The ATR of 2.84 signals moderate volatility, while the SMA 200 suggests resistance near $43.18. With AUM of $32.46M, liquidity is relatively low, which could amplify price swings. Traders should expect continued sensitivity to broader market movements, with the funds 3X leverage amplifying both gains and losses in line with the S&P 500® High Beta Index.

Additional Sources for HIBL ETF

HIBL ETF Overview

Market Cap in USD 32m
Category Trading--Leveraged Equity
TER 0.99%
IPO / Inception 2019-11-07

HIBL ETF Ratings

Growth 5y 45.4%
Fundamental -
Dividend 50.9%
Rel. Strength Industry -36.5
Analysts -
Fair Price Momentum 25.83 USD
Fair Price DCF -

HIBL Dividends

Dividend Yield 12m 0.94%
Yield on Cost 5y 4.24%
Annual Growth 5y 41.17%
Payout Consistency 62.1%

HIBL Growth Ratios

Growth Correlation 3m -52.9%
Growth Correlation 12m 23.8%
Growth Correlation 5y 18.4%
CAGR 5y 30.06%
CAGR/Max DD 5y 0.38
Sharpe Ratio 12m 0.73
Alpha -63.13
Beta 4.51
Volatility 106.05%
Current Volume 134.1k
Average Volume 20d 134.3k
What is the price of HIBL stocks?
As of March 16, 2025, the stock is trading at USD 30.09 with a total of 134,052 shares traded.
Over the past week, the price has changed by -5.23%, over one month by -36.51%, over three months by -39.81% and over the past year by -29.65%.
Is Direxion Daily SP500 High a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Direxion Daily SP500 High (NYSE ARCA:HIBL) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 45.39 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HIBL as of March 2025 is 25.83. This means that HIBL is currently overvalued and has a potential downside of -14.16%.
Is HIBL a buy, sell or hold?
Direxion Daily SP500 High has no consensus analysts rating.
What are the forecast for HIBL stock price target?
According to ValueRays Forecast Model, HIBL Direxion Daily SP500 High will be worth about 31 in March 2026. The stock is currently trading at 30.09. This means that the stock has a potential upside of +3.02%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 31 3%